BackIntact Financial Non-Cum Conv Red Perp Pfd Registered Shs A Series 7 Reg S Overview

Intact Financial Non-Cum Conv Red Perp Pfd Registered Shs A Series 7 Reg S Common Stock

Track Intact Financial Non-Cum Conv Red Perp Pfd Registered Shs A Series 7 Reg S's common stock ($8B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$8.03B
↓ 1.20% YoYΔ $-97.52M vs prior year quarter

Peer trimmed avg / median

Loading

Intact Financial Non-Cum Conv Red Perp Pfd Registered Shs A Series 7 Reg S Common Stock History

Loading

Intact Financial Non-Cum Conv Red Perp Pfd Registered Shs A Series 7 Reg S vs. peers: Common Stock Comparison

Loading

Intact Financial Non-Cum Conv Red Perp Pfd Registered Shs A Series 7 Reg S Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Intact Financial Non-Cum Conv Red Perp Pfd Registered Shs A Series 7 Reg S (IFTPF) FAQ

The latest common stock for IFTPF is $8B as of June 2026. That compares with $8.1B in the prior-year period — down 1.2% year over year. Investors often review this figure alongside Intact Financial Non-Cum Conv Red Perp Pfd Registered Shs A Series 7 Reg S's historical trend and sector peers before judging valuation or financial health.

Over the past year, IFTPF's common stock moved from $8.1B to $8B — a 1.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Intact Financial Non-Cum Conv Red Perp Pfd Registered Shs A Series 7 Reg S's operating scale or balance-sheet position.

A common stock figure of $8B for IFTPF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IFTPF's common stock ($8B), review year-over-year change from $8.1B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.